Nifty

:

23250.10

Sensex

:

76295.36

-82.25 (-0.35%)
-322.08 (-0.42%)

Login

Nifty
Sensex

:
:

23250.10
76295.36

-82.25 (-0.35%)
-322.08 (-0.42%)

JB Chemicals & Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

N/A

BSE: 506943 | NSE: JBCHEPHARM

Watchlist

NSE BSE

1716.45

06-Feb-2025

Open
High
Low
Previous Close

1739.50
1760.90
1707.00
1713.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

142923
2459.42
2030.00
1433.60

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

24,613.34
38.14
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

24,597.52
0.77%
7.23

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.78
14.44
12.85

EBITDA CAGR (%)

10 Years
5 Years
3 Years

17.36
18.77
10.46

PAT CAGR (%)

10 Years
5 Years
3 Years

18.59
15.23
12.77

P:E (Median)

8 Years
5 Years
3 Years

26.17
37.26
44.81

P:BV (Average)

8 Years
5 Years
3 Years

5.15
6.96
7.92

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.89
22.66
26.65

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 35.66 45.34 54.9 63.64
P/E Ratio 49.14 38.65 31.92 27.54
Revenue 3449 4038 4554 5114
EBITDA 892 1087 1261 1453
Net Income 553 706 858 996
ROA 14.6 16.5 18 18.3
P/B Ratio 9.3 7.85 6.55 5.47
ROE 20.45 22 22.36 21.92
FCFF 633.61 644.65 743.4 551.92
FCFF Yield 2.34 2.38 2.74 2.04

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 913.51 800.10 14.17% 955.76 836.76 14.22% 952.31 852.58 11.70% 809.20 699.14 15.74%
Expenses 668.11 585.41 14.13% 687.58 601.92 14.23% 678.93 617.75 9.90% 614.15 537.70 14.22%
EBITDA 245.40 214.69 14.30% 268.18 234.84 14.20% 273.38 234.83 16.42% 195.05 161.44 20.82%
EBIDTM 26.86% 26.83% 28.06% 28.07% 28.71% 27.54% 24.10% 23.09%
Other Income 7.16 6.61 8.32% 8.89 6.84 29.97% 5.16 5.13 0.58% 16.10 3.30 387.88%
Interest 1.85 11.52 -83.94% 2.02 9.46 -78.65% 4.32 11.21 -61.46% 8.32 12.26 -32.14%
Depreciation 41.18 33.37 23.40% 40.85 31.50 29.68% 40.01 30.65 30.54% 39.72 30.56 29.97%
PBT 209.53 176.41 18.77% 234.20 200.72 16.68% 234.21 198.10 18.23% 163.11 121.92 33.78%
Tax 53.14 48.49 9.59% 61.08 55.70 9.66% 60.98 53.53 13.92% 37.26 33.25 12.06%
PAT 156.39 127.92 22.26% 173.12 145.02 19.38% 173.23 144.57 19.82% 125.85 88.67 41.93%
PATM 17.12% 15.99% 18.11% 17.33% 18.19% 16.96% 15.55% 12.68%
EPS 10.06 8.23 22.24% 11.13 9.33 19.29% 11.14 9.30 19.78% 8.09 5.70 41.93%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 963.49 844.51 14.09% 1,000.62 881.74 13.48% 1,004.40 896.20 12.07% 861.73 762.32 13.04%
Expenses 708.98 621.39 14.10% 730.10 638.20 14.40% 724.03 664.09 9.03% 663.61 598.68 10.85%
EBITDA 254.51 223.12 14.07% 270.52 243.54 11.08% 280.37 232.11 20.79% 198.12 163.64 21.07%
EBIDTM 26.42% 26.42% 27.04% 27.62% 27.91% 25.90% 22.99% 21.47%
Other Income 8.00 7.35 8.84% 9.95 7.66 29.90% 5.89 5.63 4.62% 16.63 4.58 263.10%
Interest 2.58 12.49 -79.34% 2.06 10.37 -80.14% 5.64 12.06 -53.23% 9.41 13.96 -32.59%
Depreciation 41.94 34.03 23.24% 41.88 32.17 30.18% 40.78 31.38 29.96% 40.74 31.80 28.11%
PBT 217.99 183.95 18.51% 236.53 208.66 13.36% 239.84 194.30 23.44% 164.60 122.46 34.41%
Tax 55.50 50.38 10.16% 61.96 58.07 6.70% 63.01 51.98 21.22% 38.44 34.83 10.36%
PAT 162.49 133.57 21.65% 174.57 150.59 15.92% 176.83 142.32 24.25% 126.16 87.63 43.97%
PATM 16.86% 15.82% 17.45% 17.08% 17.61% 15.88% 14.64% 11.50%
EPS 10.45 8.62 21.23% 11.24 9.72 15.64% 11.39 9.19 23.94% 8.13 5.66 43.64%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 3,630.78 3,298.64 2,884.16 2,189.88 1,892.00 1,640.74 1,501.19 1,254.99 1,198.69 1,164.94 1,061.42 Net Sales Growth 13.87% 14.37% 31.70% 15.74% 15.31% 9.30% 19.62% 4.70% 2.90% 9.75% Cost Of Goods Sold 1,226.24 1,109.07 1,036.73 743.70 625.76 569.14 536.35 484.27 469.32 470.01 322.91 Gross Profit 2,404.54 2,189.57 1,847.44 1,446.18 1,266.24 1,071.61 964.83 770.72 729.38 694.93 738.51 GP Margin 66.23% 66.38% 64.05% 66.04% 66.93% 65.31% 64.27% 61.41% 60.85% 59.65% 69.58% Total Expenditure 2,648.77 2,421.57 2,219.47 1,681.15 1,339.66 1,272.50 1,212.75 1,072.79 980.15 939.21 868.48 Power & Fuel Cost - 87.95 91.44 71.36 62.60 61.54 63.29 58.28 54.89 55.28 53.02 % Of Sales - 2.67% 3.17% 3.26% 3.31% 3.75% 4.22% 4.64% 4.58% 4.75% 5.00% Employee Cost - 565.38 499.95 399.06 305.98 293.78 257.98 217.31 187.86 165.96 146.82 % Of Sales - 17.14% 17.33% 18.22% 16.17% 17.91% 17.19% 17.32% 15.67% 14.25% 13.83% Manufacturing Exp. - 219.93 200.49 176.57 134.52 129.40 139.89 130.97 122.68 119.24 223.30 % Of Sales - 6.67% 6.95% 8.06% 7.11% 7.89% 9.32% 10.44% 10.23% 10.24% 21.04% General & Admin Exp. - 111.97 103.42 93.33 54.90 46.11 49.84 49.82 39.08 32.06 29.92 % Of Sales - 3.39% 3.59% 4.26% 2.90% 2.81% 3.32% 3.97% 3.26% 2.75% 2.82% Selling & Distn. Exp. - 235.96 197.12 133.38 99.94 106.58 104.91 59.44 48.83 48.13 47.39 % Of Sales - 7.15% 6.83% 6.09% 5.28% 6.50% 6.99% 4.74% 4.07% 4.13% 4.46% Miscellaneous Exp. - 91.30 90.33 63.76 55.96 65.96 60.48 72.71 57.49 48.54 47.39 % Of Sales - 2.77% 3.13% 2.91% 2.96% 4.02% 4.03% 5.79% 4.80% 4.17% 4.25% EBITDA 982.01 877.07 664.69 508.73 552.34 368.24 288.44 182.20 218.54 225.73 192.94 EBITDA Margin 27.05% 26.59% 23.05% 23.23% 29.19% 22.44% 19.21% 14.52% 18.23% 19.38% 18.18% Other Income 37.31 37.02 8.65 38.80 115.92 49.57 40.23 56.21 49.51 55.68 10.41 Interest 16.51 40.52 34.31 4.95 7.19 3.16 4.57 3.41 5.00 10.29 6.65 Depreciation 161.76 135.24 111.99 71.28 67.36 65.09 54.82 55.95 46.26 40.41 37.60 PBT 841.05 738.34 527.04 471.29 593.71 349.56 269.28 179.04 216.78 230.69 159.10 Tax 212.46 194.98 138.15 110.29 146.62 71.42 87.22 51.04 43.82 51.49 45.52 Tax Rate 25.26% 26.41% 26.21% 23.40% 24.70% 21.03% 32.39% 28.51% 20.21% 22.32% 28.61% PAT 628.59 543.36 388.89 361.00 447.08 268.14 182.06 128.00 172.96 179.20 113.58 PAT before Minority Interest 628.59 543.36 388.89 361.00 447.08 268.14 182.06 128.00 172.96 179.20 113.58 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 17.31% 16.47% 13.48% 16.48% 23.63% 16.34% 12.13% 10.20% 14.43% 15.38% 10.70% PAT Growth 24.18% 39.72% 7.73% -19.25% 66.73% 47.28% 42.23% -25.99% -3.48% 57.77% EPS 40.42 34.94 25.01 23.22 28.75 17.24 11.71 8.23 11.12 11.52 7.30

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 3,830.24 3,484.18 3,149.28 2,424.24 2,042.52 1,774.73 1,643.20 1,413.77 1,368.32 1,231.58 1,144.21 Net Sales Growth 13.16% 10.63% 29.91% 18.69% 15.09% 8.00% 16.23% 3.32% 11.10% 7.64% Cost Of Goods Sold 1,295.19 1,182.05 1,168.20 842.93 701.50 630.80 596.46 542.41 552.00 491.41 341.40 Gross Profit 2,535.05 2,302.13 1,981.08 1,581.31 1,341.02 1,143.93 1,046.74 871.35 816.32 740.17 802.81 GP Margin 66.19% 66.07% 62.91% 65.23% 65.66% 64.46% 63.70% 61.63% 59.66% 60.10% 70.16% Total Expenditure 2,826.72 2,591.70 2,453.53 1,881.63 1,486.35 1,397.15 1,337.36 1,214.64 1,135.93 1,025.55 964.09 Power & Fuel Cost - 88.08 91.54 71.47 62.60 61.54 63.29 58.28 54.89 55.28 53.02 % Of Sales - 2.53% 2.91% 2.95% 3.06% 3.47% 3.85% 4.12% 4.01% 4.49% 4.63% Employee Cost - 601.41 543.45 439.24 340.60 322.92 288.18 251.10 217.34 175.31 159.56 % Of Sales - 17.26% 17.26% 18.12% 16.68% 18.20% 17.54% 17.76% 15.88% 14.23% 13.94% Manufacturing Exp. - 234.82 210.91 194.00 148.68 140.70 150.49 139.83 131.45 119.35 223.53 % Of Sales - 6.74% 6.70% 8.00% 7.28% 7.93% 9.16% 9.89% 9.61% 9.69% 19.54% General & Admin Exp. - 119.69 110.09 100.46 56.35 48.14 52.97 53.96 42.26 34.82 32.46 % Of Sales - 3.44% 3.50% 4.14% 2.76% 2.71% 3.22% 3.82% 3.09% 2.83% 2.84% Selling & Distn. Exp. - 268.40 233.96 161.80 113.22 116.95 113.59 87.44 78.27 72.72 75.13 % Of Sales - 7.70% 7.43% 6.67% 5.54% 6.59% 6.91% 6.18% 5.72% 5.90% 6.57% Miscellaneous Exp. - 97.24 95.38 71.72 63.38 76.11 72.38 81.61 59.72 76.65 75.13 % Of Sales - 2.79% 3.03% 2.96% 3.10% 4.29% 4.40% 5.77% 4.36% 6.22% 6.91% EBITDA 1,003.52 892.48 695.75 542.61 556.17 377.58 305.84 199.13 232.39 206.03 180.12 EBITDA Margin 26.20% 25.62% 22.09% 22.38% 27.23% 21.28% 18.61% 14.09% 16.98% 16.73% 15.74% Other Income 40.47 41.67 9.94 40.07 116.62 50.90 41.44 55.29 50.16 56.65 10.89 Interest 19.69 44.33 36.05 5.12 7.24 3.26 4.65 3.49 5.37 10.65 6.82 Depreciation 165.34 138.32 114.41 72.66 68.67 66.32 55.64 56.97 47.22 41.22 38.64 PBT 858.96 751.51 555.23 504.90 596.89 358.89 286.99 193.95 229.94 210.82 145.55 Tax 218.91 198.88 145.23 118.86 148.36 76.50 93.02 55.23 45.55 49.58 45.14 Tax Rate 25.49% 26.46% 26.16% 23.54% 24.86% 21.93% 32.41% 28.48% 19.81% 23.52% 31.01% PAT 640.05 552.63 409.84 385.36 447.96 272.04 193.47 138.34 184.06 161.14 100.41 PAT before Minority Interest 640.05 552.63 410.01 386.04 448.52 272.39 193.97 138.72 184.40 161.24 100.41 Minority Interest 0.00 0.00 -0.17 -0.68 -0.56 -0.35 -0.50 -0.38 -0.34 -0.10 0.00 PAT Margin 16.71% 15.86% 13.01% 15.90% 21.93% 15.33% 11.77% 9.79% 13.45% 13.08% 8.78% PAT Growth 24.50% 34.84% 6.35% -13.97% 64.67% 40.61% 39.85% -24.84% 14.22% 60.48% EPS 41.16 35.54 26.36 24.78 28.81 17.49 12.44 8.90 11.84 10.36 6.46

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,886.26 2,442.48 2,103.67 1,806.46 1,445.29 1,484.56 1,453.39 1,387.86 1,222.71 1,016.31 Share Capital 15.52 15.48 15.46 15.46 15.46 16.05 16.71 16.96 16.96 16.96 Total Reserves 2,730.90 2,305.38 2,025.56 1,791.00 1,429.83 1,468.52 1,436.67 1,370.90 1,205.74 999.35 Non-Current Liabilities 475.43 993.50 476.54 86.41 73.29 79.08 62.98 41.79 46.07 34.05 Secured Loans 23.64 383.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 Long Term Provisions 287.44 488.47 402.70 12.57 7.39 5.73 9.67 8.88 10.20 12.03 Current Liabilities 1,235.44 579.28 418.54 645.74 493.55 763.27 711.89 666.97 735.89 398.40 Trade Payables 331.65 221.71 196.24 164.02 151.88 111.33 100.22 79.03 68.61 62.31 Other Current Liabilities 431.04 236.31 77.46 86.45 100.73 87.05 112.90 118.08 119.03 82.60 Short Term Borrowings 0.00 6.71 26.32 26.43 29.49 25.80 28.48 48.86 174.40 104.73 Short Term Provisions 472.74 114.55 118.52 368.83 211.45 539.10 470.29 421.00 373.85 148.76 Total Liabilities 4,597.13 4,015.26 2,998.75 2,538.61 2,012.13 2,326.91 2,228.26 2,096.62 2,004.67 1,448.76 Net Block 1,925.42 1,821.66 1,203.67 564.60 583.21 552.11 569.91 608.69 369.35 300.87 Gross Block 2,749.15 2,522.18 1,796.83 1,108.14 1,105.15 1,011.81 979.68 963.76 679.77 571.73 Accumulated Depreciation 823.73 700.52 593.16 543.54 521.95 459.70 409.78 355.07 310.42 270.86 Non Current Assets 2,467.36 2,545.71 1,796.70 742.49 805.74 804.94 781.26 941.36 891.59 604.38 Capital Work in Progress 76.06 55.15 18.68 25.57 16.17 15.09 17.40 3.76 134.89 55.17 Non Current Investment 166.58 146.75 145.69 145.88 202.42 228.84 182.92 318.81 364.38 230.72 Long Term Loans & Adv. 293.26 507.64 427.63 5.62 3.59 8.31 10.00 9.22 22.63 17.62 Other Non Current Assets 6.03 14.51 1.04 0.82 0.36 0.59 1.03 0.88 0.33 0.00 Current Assets 2,129.78 1,469.56 1,202.05 1,796.12 1,206.39 1,521.97 1,446.99 1,155.26 1,113.08 844.38 Current Investments 364.65 192.18 0.00 664.97 333.81 360.65 383.77 224.96 247.28 366.78 Inventories 461.20 386.95 349.78 278.91 232.04 208.10 175.81 159.96 133.29 128.47 Sundry Debtors 624.78 523.58 518.05 374.11 344.24 299.85 300.54 265.10 265.67 248.49 Cash & Bank 63.70 55.76 39.67 26.43 11.56 20.77 14.95 7.20 10.71 9.06 Other Current Assets 615.45 39.23 55.77 43.60 284.74 632.60 571.92 498.05 456.13 91.58 Short Term Loans & Adv. 581.07 271.85 238.77 408.10 266.71 600.11 560.72 485.82 453.62 91.20 Net Current Assets 894.34 890.27 783.51 1,150.38 712.84 758.71 735.10 488.29 377.19 445.98 Total Assets 4,597.14 4,015.27 2,998.75 2,538.61 2,012.13 2,326.91 2,228.25 2,096.62 2,004.67 1,448.76

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 2,923.33 2,480.35 2,134.12 1,809.72 1,435.49 1,480.12 1,441.56 1,363.67 1,183.84 994.87 Share Capital 15.52 15.48 15.46 15.46 15.46 16.05 16.71 16.96 16.96 16.96 Total Reserves 2,767.97 2,343.26 2,056.01 1,794.27 1,420.03 1,464.08 1,424.84 1,346.70 1,166.87 977.91 Non-Current Liabilities 465.96 992.03 475.34 72.47 62.72 64.84 45.66 26.98 31.02 32.62 Secured Loans 23.64 383.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 Long Term Provisions 287.66 494.68 410.43 12.57 7.39 5.73 9.67 12.56 10.43 12.03 Current Liabilities 1,287.76 625.70 455.16 686.57 516.19 781.54 736.50 693.46 797.22 459.75 Trade Payables 356.31 238.65 224.48 186.92 167.97 117.37 110.39 98.98 90.85 77.51 Other Current Liabilities 435.75 240.33 81.31 89.82 102.67 93.10 119.75 122.15 138.73 103.74 Short Term Borrowings 15.34 28.02 26.32 32.64 29.49 25.80 29.29 48.86 193.02 126.88 Short Term Provisions 480.35 118.71 123.06 377.17 216.06 545.27 477.06 423.47 374.61 151.62 Total Liabilities 4,677.05 4,098.08 3,069.11 2,572.47 2,016.90 2,329.30 2,226.49 2,086.29 2,013.75 1,487.24 Net Block 2,004.40 1,901.01 1,276.99 633.65 651.26 620.93 639.50 679.44 440.22 328.56 Gross Block 2,835.23 2,607.77 1,876.20 1,182.55 1,177.43 1,084.83 1,053.76 1,038.55 753.75 601.67 Accumulated Depreciation 830.83 706.76 599.21 548.90 526.17 463.89 414.25 359.10 313.53 273.11 Non Current Assets 2,404.17 2,498.80 1,744.51 678.57 740.83 740.80 717.89 879.15 831.58 586.31 Capital Work in Progress 76.40 55.15 18.68 25.57 16.17 15.09 17.40 3.76 134.89 55.17 Non Current Investment 23.71 13.78 12.72 12.91 69.45 95.88 49.96 185.84 231.42 184.83 Long Term Loans & Adv. 293.64 514.35 435.07 5.62 3.59 8.31 10.15 9.43 22.63 17.74 Other Non Current Assets 6.03 14.51 1.04 0.82 0.36 0.59 0.88 0.67 2.43 0.00 Current Assets 2,272.87 1,599.29 1,324.61 1,893.89 1,276.08 1,588.51 1,508.59 1,207.14 1,182.16 900.94 Current Investments 364.65 192.18 0.00 664.97 333.81 360.65 383.77 224.96 247.28 366.78 Inventories 502.51 430.48 409.96 347.45 274.67 243.76 213.73 200.17 187.98 150.27 Sundry Debtors 686.92 575.80 555.69 389.02 345.43 308.22 300.73 265.97 272.64 262.35 Cash & Bank 95.54 78.81 58.53 30.85 30.95 36.80 29.92 13.39 12.90 25.19 Other Current Assets 623.25 44.91 57.43 45.95 291.22 639.08 580.44 502.66 461.34 96.35 Short Term Loans & Adv. 590.16 277.09 243.00 415.66 272.33 605.85 567.50 488.30 458.83 95.97 Net Current Assets 985.12 973.58 869.45 1,207.33 759.88 806.97 772.10 513.68 384.94 441.19 Total Assets 4,677.04 4,098.09 3,069.12 2,572.46 2,016.91 2,329.31 2,226.48 2,086.29 2,013.74 1,487.25

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 789.03 628.64 147.10 335.43 271.95 192.63 115.87 177.58 170.87 143.03 PBT 738.34 527.04 471.29 593.71 339.56 269.28 179.04 216.78 230.69 159.10 Adjustment 187.26 202.82 97.05 -56.41 15.19 26.87 14.73 10.01 -9.63 35.94 Changes in Working Capital -8.64 -12.62 -294.12 -61.45 4.34 -42.44 -39.95 -0.30 1.15 -14.04 Cash after chg. in Working capital 916.96 717.24 274.22 475.85 359.10 253.70 153.82 226.50 222.22 181.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -127.93 -88.59 -127.12 -140.41 -87.15 -61.08 -37.95 -48.91 -51.34 -37.97 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -412.45 -955.88 4.18 -230.68 23.80 -27.93 -23.97 -42.45 -51.69 -121.72 Net Fixed Assets -247.88 -761.82 -681.80 -12.39 -94.42 -29.82 -29.56 -152.86 -187.76 -69.64 Net Investments -192.30 -193.24 665.16 -274.62 53.26 -22.80 -22.92 67.89 -14.16 -61.38 Others 27.73 -0.82 20.82 56.33 64.96 24.69 28.51 42.52 150.23 9.30 Cash from Financing Activity -374.08 343.41 -137.85 -86.90 -305.48 -155.66 -59.44 -164.84 -97.46 -23.06 Net Cash Inflow / Outflow 2.50 16.17 13.42 17.86 -9.73 9.05 32.45 -29.71 21.72 -1.75 Opening Cash & Equivalents 53.88 37.69 24.26 6.37 16.11 7.09 -25.36 4.35 -14.50 10.80 Closing Cash & Equivalent 56.37 53.88 37.69 24.26 6.37 16.11 7.09 -25.36 7.23 9.06

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 800.61 625.61 170.13 314.78 275.75 194.33 122.92 201.13 140.41 126.66 PBT 751.51 555.23 504.90 596.89 348.89 286.99 193.95 229.94 212.23 145.55 Adjustment 187.22 195.78 102.27 -46.17 7.95 23.72 16.91 13.11 -1.40 38.51 Changes in Working Capital -5.64 -29.92 -302.42 -94.21 9.70 -51.47 -47.07 5.92 -16.96 -19.52 Cash after chg. in Working capital 933.10 721.09 304.75 456.50 366.55 259.24 163.79 248.97 193.88 164.53 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -132.49 -95.48 -134.62 -141.72 -90.80 -64.91 -40.87 -47.84 -53.47 -37.87 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -403.83 -961.79 2.32 -230.68 23.93 -27.67 -20.68 -45.31 -27.62 -111.89 Net Fixed Assets -247.88 -761.82 -681.80 -12.39 -94.42 -29.82 -29.56 -152.86 -187.76 -69.64 Net Investments -192.30 -193.24 665.16 -274.62 53.26 -22.80 -22.92 67.89 -14.16 -61.38 Others 36.35 -6.73 18.96 56.33 65.09 24.95 31.80 39.66 174.30 19.13 Cash from Financing Activity -385.49 356.54 -138.39 -87.42 -306.05 -155.74 -59.52 -183.84 -99.62 -1.39 Net Cash Inflow / Outflow 11.30 20.36 34.07 -3.31 -6.38 10.92 42.72 -28.02 13.17 13.38 Opening Cash & Equivalents 76.93 56.54 22.47 25.75 32.14 21.24 -21.47 6.54 -5.46 11.81 Closing Cash & Equivalent 88.22 76.93 56.54 22.47 25.75 32.14 21.24 -21.47 9.42 25.19

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 176.97 149.97 132.05 233.75 187.02 185.02 173.91 163.62 144.15 119.84 ROA 12.62% 11.09% 13.04% 19.65% 12.36% 7.99% 5.92% 8.43% 10.38% 8.14% ROE 21.45% 17.83% 18.77% 27.50% 18.30% 12.39% 9.01% 13.25% 16.01% 11.01% ROCE 25.13% 22.02% 24.04% 36.33% 22.96% 18.30% 12.50% 15.65% 19.14% 14.65% Fixed Asset Turnover 1.30 1.39 1.54 1.71 1.55 1.51 1.29 1.46 1.86 1.99 Receivable days 61.31 63.54 72.64 69.29 71.64 72.99 82.25 80.81 80.55 84.22 Inventory Days 45.28 44.94 51.19 49.29 48.96 46.67 48.83 44.65 41.01 40.66 Payable days 91.06 73.57 88.41 92.13 39.24 32.65 32.75 29.00 27.03 25.03 Cash Conversion Cycle 15.53 34.91 35.42 26.45 81.36 87.01 98.33 96.46 94.52 99.85 Total Debt/Equity 0.12 0.23 0.01 0.01 0.02 0.02 0.02 0.04 0.14 0.10 Interest Cover 19.22 16.36 96.24 83.55 108.34 59.98 53.45 44.35 23.41 24.93

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 179.35 152.42 134.02 234.17 185.75 184.47 172.50 160.77 139.57 117.31 ROA 12.60% 11.44% 13.69% 19.55% 12.53% 8.52% 6.43% 8.99% 9.21% 7.08% ROE 21.49% 18.51% 19.89% 27.64% 18.69% 13.28% 9.89% 14.48% 14.80% 9.86% ROCE 25.23% 22.79% 25.48% 36.53% 23.71% 19.59% 13.70% 16.87% 17.72% 13.49% Fixed Asset Turnover 1.32 1.46 1.63 1.73 1.57 1.54 1.35 1.53 1.82 2.03 Receivable days 63.93 63.16 69.29 65.62 67.22 67.63 73.15 71.84 79.28 78.41 Inventory Days 47.24 46.91 55.55 55.59 53.31 50.81 53.43 51.77 50.12 44.83 Payable days 91.86 72.35 89.07 92.33 38.74 32.21 33.66 32.86 32.45 27.82 Cash Conversion Cycle 19.31 37.72 35.77 28.88 81.79 86.23 92.93 90.75 96.95 95.43 Total Debt/Equity 0.13 0.23 0.01 0.02 0.02 0.02 0.02 0.04 0.16 0.13 Interest Cover 17.95 16.40 99.60 83.43 108.09 62.74 56.54 43.81 20.80 22.33

Top Investors:

axis mutual fund trustee limited a/c axis mutual fund a/c axis small cap fund

kotak emerging equity scheme

nippon life india trustee ltd-a/c nippon india pharma fund

government pension fund global

canara robeco mutual fund a/c canara robeco small cap fund

aberdeen standard sicav i - indian equity fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

USFDA completes inspection of J.B. Chemicals’ formulations manufacturing facility in Gujarat
10th Mar 2025, 10:58 AM

The said audit has been successfully completed by the USFDA with ‘No Observations’ and thus NO Form 483 was issued
Read More
JB Chem & Pharma - Quarterly Results
4th Feb 2025, 18:55 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback